Navigation Links
ABT in Medical News

Dr. Liza Solomon, HIV/AIDS Expert, Joins Abt Associates as Principal Associate in Company's Domestic Health Division

CAMBRIDGE, Mass., Aug. 5 /PRNewswire/ -- Liza Solomon, Dr.P.H., a noted HIV/AIDS public policy leader and the former Director of the Maryland State AIDS Administration has joined Abt Associates as a principal associate in its Domestic Health Division. In addition to her public service, Dr. S...

Ann Lion Coleman Joins Abt Associates to Direct USAID Health Systems 20/20 Project

CAMBRIDGE, Mass., July 31 /PRNewswire/ -- HIV/AIDS and health systems expert Ann Lion Coleman will join Abt Associates as Director for the Health Systems 20/20 project in August 2008. Health Systems 20/20 is the USAID Bureau of Global Health's flagship project working to strengthen health syst...

Leading Health Economist, Dr. Hong Wang, Joins Abt Associates

Expert in International Health Economics and Financing and Health Policy Will Play Leading Role in Health Systems 20/20 Project CAMBRIDGE, Mass., July 14 /PRNewswire/ -- Abt Associates announced that Dr. Hong Wang, M.D., Ph.D., has joined the company as a Senior Health Economist workin...

Abbott Testifies Before U.S. Congress on Role of Private Sector in Advancing Science Education

... U.S. House of Representatives Subcommittee on Research and Science Education, part of the larger Committee on Science and Technology, Abbott (NYSE: abt ) testified on its contributions as a private sector company in a multi-stakeholder, systems approach to improving kindergarten through 12th grade (K-...

Abbott and Medtronic Reach Agreement on Global Patent Disputes

... ABBOTT PARK, Ill., July 27 /PRNewswire-FirstCall/ -- Abbott (NYSE: abt ) announced today a settlement resolving all outstanding intellectual property litigation between the two parties. Under the terms of the sett...

NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test

...NM), a leading provider of cancer genetics testing services announced today that it has entered into a Strategic Supply Agreement with Abbott (NYSE: abt ). The Agreement provides for Abbott to supply materials for NeoGenomics to develop its own FISH (fluorescence in situ hybridization)-based test fo...

New Diagnostic Biomarker Test Shows Promise in Monitoring Ovarian Cancer

...t technological advancements, including the development of the very first diagnostic test to detect HIV. About Abbott Abbott (NYSE: abt ) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical product...

Abbott Introduces Molecular Diagnostic System Intended for Broad Identification of Infectious Agents

... CHICAGO, July 21 /PRNewswire-FirstCall/ -- Abbott (NYSE: abt ) today unveiled its new PLEX-ID system currently in development for detecting and characterizing a wide range of pathogens, including infectious agen...

Abbott Launches New Instrument to Complete Family of ARCHITECT Immunochemistry Analyzers

... CHICAGO, July 21 /PRNewswire-FirstCall/ -- Today at the American Association for Clinical Chemistry's Clinical Lab Expo in Chicago, Abbott (NYSE: abt ) announced the launch of a new diagnostic instrument -- the ARCHITECT(R) c4000(R) clinical chemistry analyzer which performs diagnostic tests that mo...

Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009

... ABBOTT PARK, Ill., July 15 /PRNewswire-FirstCall/ -- Abbott (NYSE: abt ) today announced financial results for the second quarter ended June 30, 2009. Diluted earnings per share, excluding specified items, ...
ABT in Medical Technology

HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials

...ms, delivering 96 test results in less than six hours for HIV-1 as compared to up to two days for other systems. About Abbott Abbott ( NYSE: abt ) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical product...

New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management

...it www.trilipix.com or call Abbott Medical Information at 1-800-633-9110 for more information about TRILIPIX. About Abbott Abbott ( NYSE: abt ) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical product...

Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years

...the Risk of Cardiac Death at Three Years ORLANDO, Fla., March 29 /PRNewswire-FirstCall/ -- Long-term data presented today from Abbott 's ( NYSE: abt ) SPIRIT II clinical trial demonstrated that the clinical advantages of the XIENCE V(R) Everolimus Eluting Coronary Stent System continued to increase...

Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial

... ABBOTT PARK, Ill., March 24 /PRNewswire-FirstCall/ -- Abbott ( NYSE: abt ) today announced the initiation of the next phase of the ABSORB clinical trial to evaluate the safety and performance of the company's fully bioabsor...

Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor

... ABBOTT PARK, Ill., and WATERTOWN, Mass., Feb. 18 /PRNewswire-FirstCall/ -- Abbott ( NYSE: abt ) and Enanta Pharmaceuticals announced today the advancement of their Hepatitis C (HCV) collaboration with a first-in-human study evaluating ABT-450, ...

Data Suggests New Antigen-Antibody Combo Test Useful for High Volume Public Health Screening

... HIV infection, who would be missed by traditional HIV antibody tests, according to research presented by Johns Hopkins University , Abbott ( NYSE: abt ) and others at the 16th Conference on Retroviruses and Opportunistic Infections (CROI). "Those with recent HIV infections who have not yet dev...

Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent

...ia, Abbott Vascular offers a comprehensive portfolio of vessel closure, endovascular and coronary products. About Abbott Abbott ( NYSE: abt ) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical product...

Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion

...otherapy treated with ESAs before and after implementation of the ESA coverage limitations," said study director Chris L. Pashos, PhD, Vice President, abt Bio-Pharma Solutions, Inc. "Our analyses found increased transfusion rates and greater blood utilization in anemic Medicare patients receiving chemot...

Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years

...rn California, Abbott Vascular offers a comprehensive portfolio of vessel closure, endovascular and coronary products. About Abbott Abbott (NYSE: abt ) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical product...

Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment

...s, is a world-class discovery and basic research facility committed to finding new treatments for autoimmune diseases. About Abbott Abbott (NYSE: abt ) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical product...
ABT in Biological Technology

USAID Selects Abt Associates to Lead Team in Strengthening Mexico Private Sector Competitiveness

CAMBRIDGE, Mass., March 11 /PRNewswire/ -- Abt Associates announced it has been awarded a 5-year, $17.8 million contract from the United States Agency for International Development (USAID) to lead a team of organizations in improving private sector competitiveness while protecting biodiversity in ...

Dr. Ricky Takai, Expert in Designing and Managing Federal Evaluation Studies in Education, Joins Abt Associates

CAMBRIDGE, Mass., Feb. 3 /PRNewswire/ -- Abt Associates announced that Ricky Takai, Ph.D., has joined the company as Principal Associate. After a brief orientation to the firm, Dr. Takai will become the leader of the company's education work in September 2009. Dr. Takai brings his more than 20 y...

Valerie DeFillipo, Reproductive Health and Rights Expert, Joins Abt Associates

New Vice President Will lead Business Development and Communications for Company's International Line of Business CAMBRIDGE, Mass., Jan. 16 /PRNewswire/ -- Abt Associates announced that Valerie DeFillipo, a reproductive health and rights expert, has joined the company as Vice President for ...

Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates

Public Health Physician Spent Last 10 Years Helping Implement World Bank HIV/AIDS and Malaria Initiatives CAMBRIDGE, Mass., Jan. 8 /PRNewswire/ -- Abt Associates announced that Dr. John Osika has joined the company as a Principal Associate and HIV/AIDS and Infectious Disease Advisor. Dr. Osi...

Karen Walton-Bowen Joins Abt Bio-Pharma Solutions, Inc., as Senior Director, Biometrics

CAMBRIDGE, Mass., Oct. 22 /PRNewswire/ -- Karen Walton-Bowen, M.Sc., C.Stat, a biostatistician with more than 20 years experience in the pharmaceutical and biotechnology industries, has joined Abt Bio-Pharma Solutions, Inc. (ABS), as Senior Director, Biometrics. An expert in clinical trials an...

Abt Associates Clinical Trials Announces Name Change to Abt Bio-Pharma Solutions, Inc.

Reflects Full Scope of Integrated Global Services CAMBRIDGE, Mass., April 1, 2008 /PRNewswire/ -- Abt Associates Clinical Trials today launches under a new name, Abt Bio-Pharma Solutions, Inc., a wholly owned subsidiary of Abt Associates Inc. The company will continue to provide cus...

SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT

IRVINE, Calif., April 23 /PRNewswire/ -- SectorWatch.biz announces the availability of MarketStats on public equities in the news and driving markets today within the biotechnology and diagnostic testing arena. MarketStats offers a perspective on the aforementioned equities and the opportunity...

Investigational Urine NGAL Biomarker Shows Promise to Monitor Cyclosporine Toxicity in Cardiac Transplant Patients

...h examples of first-of-a-kind diagnostic products and significant technological and research advancements. About Abbott Abbott (NYSE: abt ) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical product...

Abbott HIV Test Demonstrates Earlier Disease Detection

...h examples of first-of-a-kind diagnostic products and significant technological and research advancements. About Abbott Abbott (NYSE: abt ) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical product...

Abbott to Present at Barclays Global Healthcare Conference

... ABBOTT PARK, Ill., Feb. 24 /PRNewswire-FirstCall/ -- Abbott ( NYSE: abt ) will present at the Barclays Global Healthcare Conference on Tuesday, March 10, 2009. Thomas C. Freyman, executive vice president, finance and chie...
Other Tags
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
(Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
(Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
(Date:12/22/2014)... 22, 2014  The 2014 Holiday Season may ... as Acuity Market Intelligence reports that the long ... open. Acuity forecasts that intensifying demand for smart ... biometrics will drive a global market of 2.5 ... by 2020.   According to ...
(Date:12/19/2014)...   LaunchKey , the first decentralized mobile authentication ... of Things era, today announced the close of $3 ... led by Metamorphic Ventures with participation from ENIAC Ventures, ... others.  LaunchKey has raised $4 million to date, and ... and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... Dec. 16, 2014 Valencell, a leader in ... biometric technology to industry leaders such as Intel, Jabra, ... validated, biometric wearable products. These products will be showcased ... Las Vegas . "Our ... flexible and robust – with the clinical data to ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
Other Contents